South Africa’s Competition Commission probably won’t meet a new April 12 deadline to complete an investigation into Anheuser-Busch InBev NV’s takeover of SABMiller Plc, further delaying the process of gaining regulatory approval for a combination of the world’s biggest brewers.
“It’s unlikely that the case will be completed by the 12th,” Itumeleng Lesofe, spokesman for the Pretoria-based antitrust regulator, said by phone Thursday. “There are still issues that need to be considered,” he said, declining to provide specifics.
The antitrust agency needs to make a recommendation about the deal to South Africa’s Competition Tribunal, which is among regulatory authorities across the world that must sign off on the $105 billion takeover. The Commission’s previous deadline was on April 5. The maker of Budweiser has said it plans to complete the deal by the end of the year.
“We remain hopeful that there will be no unnecessary delays in South Africa, particularly as it is widely accepted that there are no competition issues,” AB InBev spokeswoman Karen Couck said in e-mailed comments. The Leuven, Belgium-based company agreed to the April 12 extension and “hope matters can be finalized shortly,” she said.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas